1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. China >
  5. Nuance Pharma Acquires Sino Health Pharmaceutical

M&A Deal Summary

Nuance Pharma Acquires Sino Health Pharmaceutical

On January 6, 2022, Nuance Pharma acquired distribution company Sino Health Pharmaceutical

Acquisition Highlights
  • This is Nuance Pharma’s 1st transaction in the Distribution sector.
  • This is Nuance Pharma’s 1st transaction in China.

M&A Deal Summary
Date 2022-01-06
Target Sino Health Pharmaceutical
Sector Distribution
Buyer(s) Nuance Pharma
Deal Type Add-on Acquisition

Target

Sino Health Pharmaceutical

China
Sino Health Pharmaceutical is a provider of sales and distribution of drugs for multinational pharmaceutical companies. Sino Health Pharmaceutical is based in China.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Nuance Pharma

Shanghai, China
Category Company
Founded 2014
Sector Life Science
DESCRIPTION

Nuance Pharma is a specialty care focused biopharma with late late-stage clinical programs and existing commercial operations. Nuance Pharma was founded in 2014 and is based in Shanghai, China.

DEAL STATS #
Overall 1 of 1
Sector: Distribution M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: China M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal